PHARMAORIGIN ApS: Financial statements 2021
CVR: 29178291
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK 40,000 compared with DKK 13,000 the year before. Equity in the 2021 report amounted to DKK 1,149,000. The solvency ratio was 99.1%.
- Profit/Loss
- DKK 40,000
- Equity
- DKK 1,149,000
- Total Assets
- DKK 1,159,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | 40 t. | 1.1 mio. | - |
| 2020 | - | - | 13 t. | 1.1 mio. | - |
| 2019 | - | - | 18 t. | 1.1 mio. | 0 |
| 2018 | - | - | -23 t. | 1.1 mio. | - |
| 2017 | - | - | -4.3 mio. | 1.1 mio. | - |
Find more companies like PHARMAORIGIN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
PHARMAORIGIN ApS has published its annual report for 2020. The net result was DKK 13,000.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees (2008). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity in the 2025 report amounted to DKK 1,477,000.